Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2019
DOI: 10.1016/j.biotechadv.2018.11.001
|View full text |Cite
|
Sign up to set email alerts
|

Three decades of nucleic acid aptamer technologies: Lessons learned, progress and opportunities on aptamer development

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
279
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 370 publications
(281 citation statements)
references
References 182 publications
1
279
0
1
Order By: Relevance
“…Aptamers are smaller and easier to prepare and modify than monoclonal antibodies, they penetrate tissue better and they show lower toxicity and immunogenicity. Therefore, aptamers are widely used for tumor detection and targeted chemotherapy [11][12][13]. The SELEX method has been used to identify an aptamer, Sgc8 that binds specifically to CEM human acute T lymphocyte leukemia cells [14,15].…”
Section: Introductionmentioning
confidence: 99%
“…Aptamers are smaller and easier to prepare and modify than monoclonal antibodies, they penetrate tissue better and they show lower toxicity and immunogenicity. Therefore, aptamers are widely used for tumor detection and targeted chemotherapy [11][12][13]. The SELEX method has been used to identify an aptamer, Sgc8 that binds specifically to CEM human acute T lymphocyte leukemia cells [14,15].…”
Section: Introductionmentioning
confidence: 99%
“…There is a combination of issues, impeding the widespread application of aptamers in the control of antimicrobial residues in foodstuffs. The reasons could be both technical (i.e., difficulty of aptamer production for small molecules, sometimes insufficient target-aptamer affinity, lack of standardized protocols) [52,53] and economical (i.e., small veterinary market, diagnostics market dominated by antibody-based assays (immunoassays) for decades, industries reluctant to invest capital in new developments to replace antibodies) [54]. Many published applications are for single analyte detection.…”
Section: Discussionmentioning
confidence: 99%
“…The reasons for the lack of aptamers available could be both technical and economical. Even though many improvements occurred in the aptamer production since 30 years, the selected aptamers sometimes do not have the desired affinity and specificity [52]. Progresses in SELEX procedures to produce performing aptamers with high binding capacity and specificity are always needed, especially for small molecules.…”
Section: Aptamers' Characteristics: Advantages and Drawbacksmentioning
confidence: 99%
“…Aptamers are functional single-stranded DNA (ssDNA) or RNA sequence that fold into complex tertiary structures and bind to specic molecular targets in a manner similar to that of antibodies. 23,24 Thus, aptamers are called "chemical antibodies". 25 The vast majority of aptamers are obtained from the Systematic Evolution of Ligands by Exponential Enrichment (SELEX) method in vitro.…”
Section: Introductionmentioning
confidence: 99%